✦ LIBER ✦

Focal Angiogenic Therapy for Myocardial Ischemia

✍ Scribed by James F. Symes

Book ID: 109219007
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 826 KB
Volume: 15
Category: Article
ISSN: 0886-0440
DOI: 10.1111/j.1540-8191.2000.tb01291.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heparin Therapy for Recent Transient Foc

Heparin Therapy for Recent Transient Focal Cerebral Ischemia

✍ KEITH, DOUGLAS S.; PHILLIPS, STEPHEN J.; WHISNANT, JACK P.; NISHIMARU, KATSUYA; 📂 Article 📅 1987 🏛 Mayo Clinic 🌐 English ⚖ 841 KB

Antianginal drug therapy for silent myoc

Antianginal drug therapy for silent myocardial ischemia

✍ William H. Frishman; Mark Teicher 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 845 KB

Thrombolytic therapy for myocardial isch

Thrombolytic therapy for myocardial ischemia and infarction

✍ Rapaport, Elliot 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 559 KB

Enhancing anti-angiogenic therapy by blo

Enhancing anti-angiogenic therapy by blocking focal adhesion kinase

✍ J.N. Bottsford-Miller; A. Sanguino; D. Thanapprapasr; M. Nishimura; H. Hee-Dong; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Combining angiogenic gene and stem cell

Combining angiogenic gene and stem cell therapies for myocardial infarction

✍ Jennifer Pons; Yu Huang; Junya Takagawa; Janice Arakawa-Hoyt; Jianqin Ye; Willia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

## Abstract ## Background Transplantation of stem cells from various sources into infarcted hearts has the potential to promote myocardial regeneration. However, the regenerative capacity is limited partly as a result of the low survival rate of the transplanted cells in the ischemic myocardium. I

Silent myocardial ischemia: Mechanisms a

Silent myocardial ischemia: Mechanisms and rationale for therapy

✍ Glen J. Kowalchuk; Richard W. Nesto 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 666 KB